Scott Andrew Smith net worth and biography

Scott Smith Biography and Net Worth

CEO of Viatris

Scott A. Smith is the Chief Executive Officer of Viatris. He joined the company’s board of directors in December 2022 and became CEO in April 2023.

Scott is a deeply knowledgeable senior global biotechnology and pharmaceutical executive with more than 35 years of experience and a proven ability to build, grow and manage large, complex organizations. His background includes substantial experience in developing and executing regulatory, clinical and business development strategies.

Before becoming CEO of Viatris, Scott served as President of BioAtla, a global biotechnology company that develops novel therapies for cancer treatment. There, he built a clinical development structure that moved multiple assets from investigational new drug applications into late-stage clinical development. He also drove the company’s long-term strategic operational plan and led all business development activities.

Scott previously served as President and Chief Operating Officer at Celgene Corporation, where he rose up the ranks with roles that included Senior Vice President and Global Head of Immunology and President of Inflammation and Immunology.

Scott earned a Bachelor of Science degree in chemistry and biology and an Honors Bachelor of Science degree in pharmacology and toxicology from Western University in Ontario, Canada, and a Master of Business Administration from Thunderbird School of Global Management in Glendale, Arizona.

He is a member of the board of directors of BioAtla and has served on the boards of multiple public and private companies including Apexigen, Titan Pharmaceuticals, Triumvira Immunologics, Refuge Biotechnologies and F-star Therapeutics.

What is Scott Andrew Smith's net worth?: The estimated net worth of Scott Andrew Smith is at least $2.66 million as of May 12th, 2025. Mr. Smith owns 292,807 shares of Viatris stock worth more than $2,661,616 as of June 12th. This net worth evaluation does not reflect any other assets that Mr. Smith may own. Learn More about Scott Andrew Smith's net worth.
How old is Scott Andrew Smith?: Mr. Smith is currently 62 years old. There are 4 older executives and no younger executives at Viatris. Learn More on Scott Andrew Smith's age.
How do I contact Scott Andrew Smith?: The corporate mailing address for Mr. Smith and other Viatris executives is 1000 MYLAN BOULEVARD, CANONSBURG PA, 15317. Viatris can also be reached via phone at (724) 514-1800 and via email at [email protected]. Learn More on Scott Andrew Smith's contact information.
Has Scott Andrew Smith been buying or selling shares of Viatris?: During the past quarter, Scott Andrew Smith has bought $536,400.00 of Viatris stock. Most recently, on Monday, May 12th, Scott Andrew Smith bought 60,000 shares of Viatris stock. The stock was acquired at an average cost of $8.94 per share, with a total value of $536,400.00. Following the completion of the transaction, the chief executive officer now directly owns 292,807 shares of the company's stock, valued at $2,617,694.58. Learn More on Scott Andrew Smith's trading history.
Who are Viatris' active insiders?: Viatris' insider roster includes Paul Campbell (CAO and Corporate Controller), W. Cornwell (Director), Robert Coury (Chairman), Michael Goettler (CEO), James Kilts (Director), JoElleng Lyons Dillon (Director), Rajiv Malik (Director), Brian Roman (Chief Legal Officer), Scott Smith (CEO), Menassie Taddese (insider), and Pauline van der Meer Morh (Director). Learn More on Viatris' active insiders.
Are insiders buying or selling shares of Viatris?: During the last twelve months, Viatris insiders bought shares 1 times. They purchased a total of 60,000 shares worth more than $536,400.00. During the last twelve months, insiders at the sold shares 7 times. They sold a total of 552,266 shares worth more than $6,421,617.66. The most recent insider tranaction occured on May, 12th when CEO Scott Andrew Smith bought 60,000 shares worth more than $536,400.00. Insiders at Viatris own 0.1% of the company. Learn More about insider trades at Viatris.
Information on this page was last updated on 5/12/2025.

Scott Andrew Smith Insider Trading History at Viatris

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/12/2025	Buy	60,000	$8.94	$536,400.00	292,807

Scott Andrew Smith Buying and Selling Activity at Viatris

Viatris Company Overview

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides it medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; and Momenta Pharmaceuticals, Inc. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

Today's Range

Now: $9.09

$8.92

$9.19

50 Day Range

MA: $8.30

$7.26

$9.10

2 Week Range

Now: $9.09

$6.85

$13.55

Volume

13,592,067 shs

Average Volume

10,933,479 shs

Market Capitalization

$10.67 billion

P/E Ratio

N/A

Dividend Yield

5.67%

Beta

0.9

Scott Smith Biography and Net Worth

What is Scott Andrew Smith's net worth?

How old is Scott Andrew Smith?

How do I contact Scott Andrew Smith?

Has Scott Andrew Smith been buying or selling shares of Viatris?

Who are Viatris' active insiders?

Are insiders buying or selling shares of Viatris?